NO971811L - Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler - Google Patents
Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidlerInfo
- Publication number
- NO971811L NO971811L NO971811A NO971811A NO971811L NO 971811 L NO971811 L NO 971811L NO 971811 A NO971811 A NO 971811A NO 971811 A NO971811 A NO 971811A NO 971811 L NO971811 L NO 971811L
- Authority
- NO
- Norway
- Prior art keywords
- tnf
- compounds
- formula
- tetrahydropyrazolopyridines
- bicyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Forbindelser med formelen. hvor R, R, R.og X er som definert. Forbindelsene med formel I og farmasøytisk godtagbare salter derav er nyttig for å hemme fosfodiesterase (PDE) type IV og produksjon av tumor-nekrose-faktor(TNF) og for behandling av astma, artritt, bronkitt, kronisk obstruktiv luftveissykdom, psoriasis, allergisk rhinitt, dermatitt og andre inflammatoriske sykdommer, AIDS, septisk sjokk og andre sykdommer som involverer produksjon av TNF.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32643494A | 1994-10-20 | 1994-10-20 | |
| PCT/IB1995/000847 WO1996012720A1 (en) | 1994-10-20 | 1995-10-06 | Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO971811D0 NO971811D0 (no) | 1997-04-18 |
| NO971811L true NO971811L (no) | 1997-06-18 |
Family
ID=23272184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971811A NO971811L (no) | 1994-10-20 | 1997-04-18 | Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0787132A1 (no) |
| JP (1) | JPH09511758A (no) |
| KR (1) | KR970707124A (no) |
| CN (1) | CN1050129C (no) |
| AU (1) | AU702105B2 (no) |
| BR (1) | BR9504491A (no) |
| CZ (1) | CZ120097A3 (no) |
| FI (1) | FI954991L (no) |
| HU (1) | HUT77517A (no) |
| IL (1) | IL115667A0 (no) |
| MX (1) | MX9504422A (no) |
| NO (1) | NO971811L (no) |
| NZ (1) | NZ292991A (no) |
| PL (1) | PL319758A1 (no) |
| WO (1) | WO1996012720A1 (no) |
| ZA (1) | ZA958839B (no) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2001002304A0 (en) * | 1996-05-03 | 2001-12-31 | Pfizer | Substituted indazole derivatives and related compounds |
| EP0934307B1 (en) | 1996-06-19 | 2011-04-27 | Aventis Pharma Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| CN1080260C (zh) * | 1996-06-25 | 2002-03-06 | 美国辉瑞有限公司 | 取代的吲哚衍生物以及它们作为iv型磷酸二酯酶(pde)和肿瘤坏死因子(tnf)抑制剂的用途 |
| ES2172882T3 (es) * | 1997-05-08 | 2002-10-01 | Pfizer Prod Inc | Procedimientos y productos intermedios para la preparacion de derivados indazol sustituidos. |
| IL126745A (en) * | 1997-11-04 | 2003-09-17 | Pfizer Prod Inc | Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors |
| EA004515B1 (ru) | 1998-12-23 | 2004-04-29 | Дюпон Фармасьютикалз Компани | АЗОТСОДЕРЖАЩИЕ ГЕТЕРОБИЦИКЛЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Xa |
| US6858616B2 (en) | 1998-12-23 | 2005-02-22 | Bristol-Myers Squibb Pharma Company | Nitrogen containing heterobicycles as factor Xa inhibitors |
| US6326495B2 (en) | 1999-04-30 | 2001-12-04 | Pfizer Inc. | Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein |
| SK287231B6 (sk) | 1999-08-21 | 2010-04-07 | Nycomed Gmbh | Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora |
| DE60143041D1 (de) * | 2000-08-10 | 2010-10-21 | Pfizer Italia Srl | Bizyklische pyrazole wirksam als kinase inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
| US6998408B2 (en) | 2001-03-23 | 2006-02-14 | Bristol-Myers Squibb Pharma Company | 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors |
| CA2441772A1 (en) | 2001-04-18 | 2002-10-31 | Bristol-Myers Squibb Company | 1,4,5,6-tetrahydropyrazolo-¬3,4-c|-pyridin-7-ones as factor xa inhibitors |
| WO2002085356A1 (en) | 2001-04-18 | 2002-10-31 | Bristol-Myers Squibb Company | 1, 4, 5, 6-tetrahydropyrazolo-[3, 4-c]-pyrid in-7-ones as factor xa inhibitors |
| JP4196678B2 (ja) * | 2001-04-26 | 2008-12-17 | 味の素株式会社 | 複素環化合物 |
| TWI331526B (en) | 2001-09-21 | 2010-10-11 | Bristol Myers Squibb Pharma Co | Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| CN101357914A (zh) | 2001-09-21 | 2009-02-04 | 百时美施贵宝公司 | 含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂 |
| AU2003244632A1 (en) * | 2002-07-25 | 2004-02-25 | Pharmacia Italia S.P.A. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| WO2004087211A2 (en) | 2003-04-01 | 2004-10-14 | Applied Research Systems Ars Holding N.V. | Inhibitors of phosphodiesterases in infertility |
| AR045037A1 (es) * | 2003-07-10 | 2005-10-12 | Aventis Pharma Sa | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. |
| FR2857363B1 (fr) * | 2003-07-10 | 2007-09-07 | Aventis Pharma Sa | 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation |
| TW200736255A (en) | 2005-12-01 | 2007-10-01 | Elan Pharm Inc | 5-(Substituted)-pyrazolopiperidines |
| AU2009243232A1 (en) | 2008-04-30 | 2009-11-05 | Fredrik Almqvist | New peptidomimetic compounds |
| JP6062633B2 (ja) | 2009-01-28 | 2017-01-18 | カラ セラピューティクス インコーポレイテッド | 二環式ピラゾロ複素環類 |
| US7741350B1 (en) | 2009-01-28 | 2010-06-22 | Cara Therapeutics, Inc. | Bicyclic pyrazolo-heterocycles |
| EP3152206A1 (en) * | 2014-06-06 | 2017-04-12 | Biogen MA Inc. | Atx modulating agents |
| CN115043768A (zh) * | 2022-06-20 | 2022-09-13 | 新乡市润宇新材料科技有限公司 | 一种酸促进环丙基开环合成n-芳基吡咯烷-2-酮的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1463883A (fr) * | 1964-09-08 | 1966-07-22 | Ciba Geigy | Procédé de préparation de triaza-composés bicycliques |
| US3365459A (en) * | 1964-09-08 | 1968-01-23 | Ciba Geigy Corp | Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives |
| US3340269A (en) * | 1964-09-08 | 1967-09-05 | Ciba Geigy Corp | 1-substituted 4-acyl-2, 3-dioxo-piperidine |
| EP0707585A1 (en) * | 1993-07-06 | 1996-04-24 | Pfizer Inc. | Bicyclic tetrahydro pyrazolopyridines |
-
1995
- 1995-10-06 NZ NZ292991A patent/NZ292991A/xx unknown
- 1995-10-06 HU HU9702289A patent/HUT77517A/hu unknown
- 1995-10-06 WO PCT/IB1995/000847 patent/WO1996012720A1/en not_active Ceased
- 1995-10-06 JP JP8513751A patent/JPH09511758A/ja active Pending
- 1995-10-06 PL PL95319758A patent/PL319758A1/xx unknown
- 1995-10-06 EP EP95932148A patent/EP0787132A1/en not_active Withdrawn
- 1995-10-06 CZ CZ971200A patent/CZ120097A3/cs unknown
- 1995-10-06 KR KR1019970702557A patent/KR970707124A/ko not_active Abandoned
- 1995-10-06 CN CN95195743A patent/CN1050129C/zh not_active Expired - Fee Related
- 1995-10-06 AU AU35317/95A patent/AU702105B2/en not_active Ceased
- 1995-10-18 IL IL11566795A patent/IL115667A0/xx unknown
- 1995-10-19 MX MX9504422A patent/MX9504422A/es unknown
- 1995-10-19 FI FI954991A patent/FI954991L/fi unknown
- 1995-10-19 ZA ZA958839A patent/ZA958839B/xx unknown
- 1995-10-20 BR BR9504491A patent/BR9504491A/pt not_active Application Discontinuation
-
1997
- 1997-04-18 NO NO971811A patent/NO971811L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1161040A (zh) | 1997-10-01 |
| FI954991A7 (fi) | 1996-04-21 |
| HUT77517A (hu) | 1998-05-28 |
| KR970707124A (ko) | 1997-12-01 |
| ZA958839B (en) | 1997-04-21 |
| FI954991L (fi) | 1996-04-21 |
| CZ120097A3 (cs) | 1998-01-14 |
| IL115667A0 (en) | 1996-01-19 |
| MX9504422A (es) | 1997-04-30 |
| BR9504491A (pt) | 1997-05-20 |
| WO1996012720A1 (en) | 1996-05-02 |
| AU3531795A (en) | 1996-05-15 |
| JPH09511758A (ja) | 1997-11-25 |
| FI954991A0 (fi) | 1995-10-19 |
| AU702105B2 (en) | 1999-02-11 |
| EP0787132A1 (en) | 1997-08-06 |
| PL319758A1 (en) | 1997-08-18 |
| CN1050129C (zh) | 2000-03-08 |
| NZ292991A (en) | 1999-02-25 |
| NO971811D0 (no) | 1997-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971811L (no) | Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler | |
| CA2166721A1 (en) | Bicyclic tetrahydro pyrazolopyridines | |
| FI945555A0 (fi) | Substituoituja oksindoleja | |
| CA2150812A1 (en) | Catechol diethers as selective pde iv inhibitors | |
| DE60004655T2 (de) | Pyridin- und pyrimidinderivate und deren verwendung als inhibitor von cytokinbedingten krankheiten | |
| DE60315674D1 (de) | Neue imidazopyridine und ihre verwendung | |
| WO2004024728A3 (en) | Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors | |
| TR200100433T2 (tr) | Fosfodiesteraz 4 önleyicileri olarak ikame edilmiş 1,8-naftiridin-4(1H)-onlar | |
| NO962386L (no) | Heterocykliske ring-kondenserte pyrimidin-derivater | |
| NO980313L (no) | N-(aroyl)glysin-hydroksaminsyre-derivater og beslektete forbindelser | |
| MY116527A (en) | Tricyclic 5, 6-dihydro-9h-pyrazolo [3,4,-c]-1,2,4- triazolo [4,3-a] pyridines | |
| DE60305514D1 (de) | Neue verwendung von benzothiazolderivaten | |
| DK0869945T3 (da) | Catecholdiethere derivater nyttige som farmaceutisk middel | |
| RU2738837C2 (ru) | Некоторые ингибиторы протеинкиназы | |
| DE60103035D1 (de) | Neue verwendung von phenylheteroalkylamin-derivaten | |
| WO2009110519A1 (ja) | 新規1-アミノカルボニルピペリジン誘導体 | |
| AU580050B2 (en) | Triazolopyrimidine derivatives | |
| MY135776A (en) | PYRAZOLO [3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS |